Repligen To Restate Financial Statements For 2023 And Early 2024, No Impact On Business Operations Or Strategic Outlook; Reaffirms 2024 Revenue Guidance, Adjusting FY Range To $627M-$642M After $6.6M Understatement
Portfolio Pulse from Benzinga Newsdesk
Repligen will restate its financial statements for 2023 and early 2024 due to a $6.6M understatement but assures no impact on business operations or strategic outlook. The company reaffirms its 2024 revenue guidance, adjusting the fiscal year range to $627M-$642M.
September 18, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Repligen is restating its financials for 2023 and early 2024 due to a $6.6M understatement. The company maintains that this will not affect its business operations or strategic outlook and reaffirms its 2024 revenue guidance, adjusting the fiscal year range to $627M-$642M.
The restatement of financials due to a $6.6M understatement could raise concerns about financial accuracy, but the company reassures no impact on operations or strategy. The reaffirmation of 2024 revenue guidance suggests stability, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100